On the Road to Better Pancreatic Cancer Treatments

purpleSTRIDErun_300x300

Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand the unique metabolism of pancreatic tumors and discover new therapeutic targets that can exploit the dependency of these tumors on the nutrients that fuel their growth.

Read More

Q&A With Lee Helman, MD, on New Cancer Targets and Therapeutics

Helman_Photo_external

The National Cancer Institute’s Lee Helman, MD, co-chair of the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, discusses what to expect this year, and peers into the future of targeted cancer therapies and immunotherapy.

Read More

Progress Against Cancer: An Ongoing Goal That Needs Increased Federal Investment

Carlos Arteaga headshot

In follow up to the AACR Cancer Progress Report 2014, AACR President Carlos L. Arteaga, MD, discusses our continuing progress against cancer, including recent FDA decisions that provide patients with new options for cancer prevention and treatment, and the continuing need for federal investment in biomedical research.

Read More